The Healthcare Digitalisation Gap: Why PE's Favourite Sector Is the Hardest to Digitise
2026 healthcare PE has pivoted from roll-up consolidation to tech-enabled care, but the deal thesis and the portfolio reality have never been further apart. What the digitalisation gap is, why it exists, and who closes it.
Healthcare has been private equity's favourite sector for a decade, and in 2026 the pitch has changed. The roll-up era, buy the practices, consolidate the back office, exit the platform, has run out of road. The new thesis is tech-enabled care: AI in the revenue cycle, analytics on the clinical data, a software margin story layered over a services business. The problem is that the companies being asked to deliver that story are the same fragmented, integration-indebted platforms the roll-up era built. The distance between the two is the digitalisation gap, and it is quietly becoming the defining operational problem of this healthcare cycle.
The 2026 shift: from roll-up to tech-enabled care
The evidence that the thesis has rotated is not subtle. At HPE Miami 2026, 47% of respondents cited health IT and AI-enabled services as the main deal driver for the year, ahead of every consolidation category that dominated the last cycle. Bain's Global Healthcare Private Equity Report 2026 documents the consequence: platforms with production-grade AI and proprietary data assets are commanding premiums, while plain consolidation stories are not.
Deal activity in the first half of the year followed the money. New Mountain Capital has been pursuing AI-enabled platforms. General Atlantic, Warburg Pincus and TA Associates stayed active through add-ons rather than new platforms. The Q2 pattern was consistent: physician practice consolidation continues, but the headline acquisitions are AI-enabled technology assets and outpatient expansion, not another tuck-in at a lower multiple.
In other words, the consolidation playbook still exists, but it no longer carries the valuation. The multiple now lives in the technology story.
What the deal thesis says
Inside the IC memo, the logic is clean. A primary care platform with 40 clinics generates a proprietary clinical and financial dataset. Deploy AI against the revenue cycle and you recover margin. Deploy analytics against the clinical data and you improve outcomes, which improves payer negotiations. At exit, the buyer is not paying a services multiple for a staffing business, they are paying a technology multiple for a data asset. Every healthcare deck now has this slide. Most have three.
The premium math makes the slide mandatory. If AI-enabled platforms clear the market at two or three turns above consolidation-era comps, then the difference between "practice group" and "tech-enabled care platform" is worth more than the entire operational improvement plan underneath it. No deal team can leave that on the table, so the digitalisation assumption goes into the model whether or not anyone has walked a clinic floor.
What the portfolio reality says
Then the deal closes, and the operating partner inherits the actual company.
The typical PE-backed primary care platform is not one business. It is fifteen acquisitions wearing a brand. Each practice arrived with its own EHR instance, its own billing conventions, its own scheduling logic. Some platforms run five different EHR systems; plenty run more than one instance of the same system, configured incompatibly. The proprietary dataset in the deck does not exist yet. What exists is fifteen datasets that disagree with each other.
Reimbursement adds a moving floor. Payer mix shifts, value-based contracts arrive mid-hold, and a rules change can reprice the revenue cycle the AI was meant to optimise. A model trained on this year's billing reality can be stale before the integration finishes.
Clinicians add the human constraint. Physicians did not sell their practices to spend evenings learning a new documentation workflow, and a rollout that adds clicks to a clinical day will be worked around, not adopted. Change management in healthcare happens at clinic level, one workflow at a time, not at platform level in a steering committee.
And underneath all of it sits the debt from the last era. Integration work that was deferred when the thesis was consolidation, unmerged systems, unstandardised data, unresolved operating models, compounds directly into digitalisation debt. The platform is being asked to digitise on foundations it never finished building.
The digitalisation gap, defined
The digitalisation gap is the distance between the technology transformation assumed in a private equity deal thesis and the operational capacity of the portfolio company to absorb it during the hold period.
It is not a technology problem. The software works. It is an absorption problem: the gap between what the model assumes the company can implement and what the company can actually metabolise while running clinics, integrating add-ons and hitting a quarterly EBITDA plan. In healthcare the gap is wider than in any other PE sector, because the absorption capacity is constrained by clinical workflows, regulatory exposure and the fragmentation the roll-up era left behind.
Who actually does this work
Four honest options, each with a trade-off.
In-house portfolio operations groups. Funds with a captive portfolio operations group can put a dedicated resource on the problem and keep the learning inside the fund. The constraint is bandwidth: one digital lead across a dozen portfolio companies is a prioritisation exercise, not a transformation team.
Large consultancies. Alvarez & Marsal, West Monroe and their peers bring genuine healthcare IT depth and can staff a programme tomorrow. The trade-off is cost and transfer: the programme tends to leave when the consultants do.
Growth execution firms. A smaller category of firms, Claymore Partners among them, embeds with the management team and runs the workstream from inside the operating cadence rather than alongside it. The trade-off is scale: embedded models are built for depth on one platform, not breadth across twenty.
Specialist health IT vendors. EHR consolidation shops and revenue-cycle specialists execute their slice well. The trade-off is that somebody still has to own the whole, and a vendor cannot own the operating model of a company they bill by the milestone.
The operator playbook: what good looks like
- Sequence EHR consolidation before analytics. Analytics on a fragmented estate produces confident nonsense. One system of record first, dashboards second, AI third.
- Put one accountable owner on the platform, not one per clinic. Digitalisation run as fifteen local projects produces fifteen local outcomes. It is a platform workstream with a single name attached.
- Budget it in the value creation plan, not the IT line. If digitalisation is funded as infrastructure, it will be cut as infrastructure. It is a value-creation workstream with its own milestones and its own return case.
- Measure clinician adoption, not deployment. "Live in all clinics" is a vendor metric. The operator metric is whether physicians use the workflow without workarounds a month later.
- Start in the 100-day plan, not year three. The EHR baseline, the owner and the budget belong in the first hundred days. Every quarter of delay adds integration debt at the exact moment the exit clock is running.
FAQ
What is the digitalisation gap in PE-backed healthcare?
The digitalisation gap is the distance between the technology transformation assumed in a private equity deal thesis and the operational capacity of the portfolio company to absorb it during the hold period.
Why are PE firms paying premiums for AI-enabled healthcare platforms in 2026?
Proprietary data assets and production-grade AI raise exit multiples. At HPE Miami 2026, 47% of respondents cited health IT and AI-enabled services as the main deal driver, and Bain's 2026 global healthcare report documents premiums for platforms that have both.
Why is digitalisation harder in primary care platforms than in other portfolio companies?
Because most primary care platforms were built by roll-up. They carry fragmented EHR estates across acquired practices, reimbursement complexity that can shift mid-hold, and clinician workflows where change has to be managed clinic by clinic rather than at platform level.
Who helps PE-backed healthcare companies digitise?
Four categories: in-house portfolio operations groups, large consultancies with healthcare IT practices, growth execution firms that embed with the management team, and specialist health IT vendors that execute defined workstreams such as EHR consolidation or revenue cycle.
What should the 100-day plan cover on digital for a healthcare platform?
Baseline the EHR estate, name one accountable owner for digitalisation across the platform, and fund it as a value-creation workstream with its own milestones rather than an IT line item.
Related reading: What is a value creation plan in private equity · In-house portfolio operations group vs external operating partner firm · Why buy-and-build deals fail